MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cortical thickness analysis in Parkinson’s disease with urinary symptoms

R. Roh, K. Kim, K. Koh (Seoul, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1049

Keywords: Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: This study aimed to identify the significant region which can be related to urinary symptoms in Parkinson’s disease using correlation analysis between non-motor symptoms assessment scale(NMSS) domain 7 and cortical thickness of various areas.

Background: Various non-motor symptoms are present and emerge with disease progression in Parkinson’s disease. Among these non-motor symptoms, urinary symptoms such as frequency, nocturia and urgency are not only common problems but also can contribute to impaired quality of life. However, exact mechanism causing urinary problems in Parkinson’s disease have not been known well.

Method: Total 91 patients who were diagnosed as idiopathic Parkinson’s disease between January 2010 and December 2017 were enrolled. And the correlation analysis between their NMSS domain 7 scale (which were constituted of three components ; frequency, urgency, nocturia and can measure the severity of urinary symptoms in Parkinson’s disease) and cortical thickness was conducted using Freesurfer image analysis suiteversion 6.0.(Martinos Center, Havard University, Boston, MA; http://surfer.nmr.mgh.harvard.edu)

Results: In correlation analysis between NMSS domain 7 scale and cortical thickness, supramarginal(p=.018), precuneus(p=.005), temporal pole(p=.014), precentral(p=.019) area of left hemisphere were significantly inverse-correlated with NMSS domain 7 scale. And we can also find that the insula(p=.003), precuneous(p=.002), parsorbitalis(p=.040) area of right hemisphere had significant inverse correlation to NMSS domain 7 scale.(Figure 1)

Conclusion: This study demonstrates significant inverse correlation between cortical thickness of various cortices in bilateral hemisphere and NMSS domain 7 scale. Although it is unclear that how these cortices are associated exactly with the urinary disorder in Parkinson’s disease, it can provide us a hypothesis that various cortices with a significant inverse-correlation with NMSS domain 7 scale may represent a trait marker for urinary symptoms in Parkinson’s disease.

PD Correlation Figure 1

To cite this abstract in AMA style:

R. Roh, K. Kim, K. Koh. Cortical thickness analysis in Parkinson’s disease with urinary symptoms [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cortical-thickness-analysis-in-parkinsons-disease-with-urinary-symptoms/. Accessed September 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cortical-thickness-analysis-in-parkinsons-disease-with-urinary-symptoms/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley